359 related articles for article (PubMed ID: 15178639)
21. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes.
Morin N; Lizcano JM; Fontana E; Marti L; Smih F; Rouet P; Prévot D; Zorzano A; Unzeta M; Carpéné C
J Pharmacol Exp Ther; 2001 May; 297(2):563-72. PubMed ID: 11303044
[TBL] [Abstract][Full Text] [Related]
22. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
[TBL] [Abstract][Full Text] [Related]
23. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
Solé M; Miñano-Molina AJ; Unzeta M
Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
[TBL] [Abstract][Full Text] [Related]
24. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
25. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas.
Göktürk C; Nilsson J; Nordquist J; Kristensson M; Svensson K; Söderberg C; Israelson M; Garpenstrand H; Sjöquist M; Oreland L; Forsberg-Nilsson K
Am J Pathol; 2003 Nov; 163(5):1921-8. PubMed ID: 14578191
[TBL] [Abstract][Full Text] [Related]
27. Exploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity.
Marti L; Abella A; De La Cruz X; García-Vicente S; Unzeta M; Carpéné C; Palacín M; Testar X; Orozco M; Zorzano A
J Med Chem; 2004 Sep; 47(20):4865-74. PubMed ID: 15369390
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
29. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Obata T
Life Sci; 2006 Jun; 79(5):417-22. PubMed ID: 16487546
[TBL] [Abstract][Full Text] [Related]
30. Benzylamine antihyperglycemic effect is abolished by AOC3 gene invalidation in mice but not rescued by semicarbazide-sensitive amine oxidase expression under the control of aP2 promoter.
Grès S; Bour S; Valet P; Carpéné C
J Physiol Biochem; 2012 Dec; 68(4):651-62. PubMed ID: 22547093
[TBL] [Abstract][Full Text] [Related]
31. Semicarbazide-sensitive amine oxidase substrates fail to induce insulin-like effects in fat cells from AOC3 knockout mice.
Bour S; Prévot D; Guigné C; Stolen C; Jalkanen S; Valet P; Carpéné C
J Neural Transm (Vienna); 2007; 114(6):829-33. PubMed ID: 17406965
[TBL] [Abstract][Full Text] [Related]
32. Vascular adhesion protein-1 in human ischaemic stroke.
Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S
Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
35. Increased primary amine oxidase expression and activity in white adipose tissue of obese and diabetic db-/- mice.
Iffiú-Soltész Z; Mercader J; Daviaud D; Boucher J; Carpéné C
J Neural Transm (Vienna); 2011 Jul; 118(7):1071-7. PubMed ID: 21298297
[TBL] [Abstract][Full Text] [Related]
36. Regulation of semicarbazide-sensitive amine oxidase expression by tumor necrosis factor-alpha in adipocytes: functional consequences on glucose transport.
Mercier N; Moldes M; El Hadri K; Fève B
J Pharmacol Exp Ther; 2003 Mar; 304(3):1197-208. PubMed ID: 12604697
[TBL] [Abstract][Full Text] [Related]
37. Vascular adhesion protein-1, a novel molecule, in kidney and heart allograft recipients.
Koc-Zorawska E; Przybylowski P; Malyszko JS; Mysliwiec M; Malyszko J
Transplant Proc; 2013 Jun; 45(5):2009-12. PubMed ID: 23769096
[TBL] [Abstract][Full Text] [Related]
38. Vascular adhesion protein-1: Role in human pathology and application as a biomarker.
Pannecoeck R; Serruys D; Benmeridja L; Delanghe JR; van Geel N; Speeckaert R; Speeckaert MM
Crit Rev Clin Lab Sci; 2015; 52(6):284-300. PubMed ID: 26287391
[TBL] [Abstract][Full Text] [Related]
39. Macrovascular changes in mice overexpressing human semicarbazide-sensitive amine oxidase in smooth muscle cells.
Gokturk C; Sugimoto H; Blomgren B; Roomans GM; Forsberg-Nilsson K; Oreland L; Sjoquist M
Am J Hypertens; 2007 Jul; 20(7):743-50. PubMed ID: 17586408
[TBL] [Abstract][Full Text] [Related]
40. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
